188 related articles for article (PubMed ID: 37310446)
21. NLX-112, a highly selective 5-HT
Depoortère R; Bergman J; Beardsley PM; Desai RI; Paronis CA; Walentiny DM; Varney MA; Newman-Tancredi A
Neuropharmacology; 2022 Jun; 210():109025. PubMed ID: 35276118
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
Broadbear JH; Depoortere RY; Vacy K; Ralph D; Tunstall BJ; Newman-Tancredi A
Behav Pharmacol; 2021 Dec; 32(8):652-659. PubMed ID: 34751175
[TBL] [Abstract][Full Text] [Related]
23. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements.
McCreary AC; Varney MA; Newman-Tancredi A
Neuropharmacology; 2016 Jun; 105():651-660. PubMed ID: 26777281
[TBL] [Abstract][Full Text] [Related]
24. Serotonin 5-HT
Levigoureux E; Vidal B; Fieux S; Bouillot C; Emery S; Newman-Tancredi A; Zimmer L
ACS Chem Neurosci; 2019 Jul; 10(7):3108-3119. PubMed ID: 30576601
[TBL] [Abstract][Full Text] [Related]
25. Biased 5-HT
van Hagen BTJ; van Goethem NP; Nelissen E; Paes D; Koymans K; van Hoof S; Schreiber R; Varney M; Newman-Tancredi A; Prickaerts J
Mol Cell Neurosci; 2022 May; 120():103719. PubMed ID: 35283305
[TBL] [Abstract][Full Text] [Related]
26. NLX-101, a 5-HT
Aguiar RP; Soares LM; Varney M; Newman-Tancredi A A; Milani H; Prickaerts J; de Oliveira RMW
Neurobiol Aging; 2023 Apr; 124():52-59. PubMed ID: 36739621
[TBL] [Abstract][Full Text] [Related]
27. Chronic oral ketamine prevents anhedonia and alters neuronal activation in the lateral habenula and nucleus accumbens in rats under chronic unpredictable mild stress.
Kingir E; Sevinc C; Unal G
Neuropharmacology; 2023 May; 228():109468. PubMed ID: 36813161
[TBL] [Abstract][Full Text] [Related]
28. In vivo biased agonism at 5-HT
Vidal B; Fieux S; Redouté J; Villien M; Bonnefoi F; Le Bars D; Newman-Tancredi A; Costes N; Zimmer L
Neuropsychopharmacology; 2018 Oct; 43(11):2310-2319. PubMed ID: 30030540
[TBL] [Abstract][Full Text] [Related]
29. The selective 5-HT
Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression.
Zvozilova A; Bukatova S; Koprdova R; Mach M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791304
[TBL] [Abstract][Full Text] [Related]
31. Alnespirone (S 20499), an agonist of 5-HT1A receptors, and imipramine have similar activity in a chronic mild stress model of depression.
Muñoz C; Papp M
Pharmacol Biochem Behav; 1999 Aug; 63(4):647-53. PubMed ID: 10462194
[TBL] [Abstract][Full Text] [Related]
32. Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.
Fu W; Xie H; Laudon M; Zhou S; Tian S; You Y
Psychopharmacology (Berl); 2016 Jun; 233(12):2229-39. PubMed ID: 27007604
[TBL] [Abstract][Full Text] [Related]
33. From Receptor Selectivity to Functional Selectivity: The Rise of Biased Agonism in 5-HT1A Receptor Drug Discovery.
Sniecikowska J; Newman-Tancredi A; Kolaczkowski M
Curr Top Med Chem; 2019; 19(26):2393-2420. PubMed ID: 31544717
[TBL] [Abstract][Full Text] [Related]
34. The Serotonin 1A (5-HT
Smith ALW; Harmer CJ; Cowen PJ; Murphy SE
CNS Drugs; 2023 Jul; 37(7):571-585. PubMed ID: 37386328
[TBL] [Abstract][Full Text] [Related]
35. Behavioural characteristics and sex differences of a treatment-resistant depression model: Chronic mild stress in the Wistar-Kyoto rat.
Loizeau V; Durieux L; Mendoza J; Wiborg O; Barbelivien A; Lecourtier L
Behav Brain Res; 2024 Feb; 457():114712. PubMed ID: 37838247
[TBL] [Abstract][Full Text] [Related]
36. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
[TBL] [Abstract][Full Text] [Related]
37. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
[TBL] [Abstract][Full Text] [Related]
38. Acute and Repeated Administration of NLX-101, a Selective Serotonin-1A Receptor Biased Agonist, Reduces Audiogenic Seizures in Developing Fmr1 Knockout Mice.
Tao X; Newman-Tancredi A; Varney MA; Razak KA
Neuroscience; 2023 Jan; 509():113-124. PubMed ID: 36410632
[TBL] [Abstract][Full Text] [Related]
39. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
40. Improvement of lower urinary tract function by a selective serotonin 5-HT
Lin CY; Sparks A; Lee YS
Exp Neurol; 2020 Oct; 332():113395. PubMed ID: 32615138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
